Navigation Links
InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac, an Animal Free Reagent for Bacterial Fermentation
Date:11/10/2009

InVitria's Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation.

Fort Collins, CO (PRWEB) November 10, 2009 -- Manufactured in an animal free production system, InVitria's Lysobac is a cost-effective, more consistent and performance enhancing alternative to chicken lysozyme, also called hen egg white lysozyme (HEWL).

Now, InVitria will meet the demand of large commercial users who require metric ton quantities of bacterial cell lysis reagents. "With the increase in production capacity at our ISO 9001 facility, we now have the ability to supply large volumes of Lysobac to commercial customers all over the world," said Greg Unruh, Vice President of Production.

"InVitria customers have achieved significant performance and safety benefits from using Lysobac as a cell lysis reagent," said Scott Deeter, President and CEO. "Further, Lysobac allows manufacturers to switch to an animal free production system and avoid the risk of contaminants from animal derived components," said Deeter.

Lysobac offers substantial advantages over chicken lysozyme and mechanical lysis, including:

 
  • Animal free
  • Greater than 4x more active than chicken lysozyme (units/mg protein)
  • Delivers more recombinant protein yield
  • Consistent from lot-to-lot
  • Improves bioprocessing efficiency
  • Reduces overall production costs

Through December 1, 2009, InVitria is offering a FREE Papa John's Pizza gift card for all Lysobac orders placed through InVitria's WebStore. Visit Lysobac Online to place your order.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media and bacterial cell lysis supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products, please contact InVitria's Product Support team at info@invitria.com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/BacterialFermentation/chickenlysozymeHEWL/prweb3182554.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria to Present at WilBio's International Cell Engineering Meeting
2. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
3. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
4. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
5. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
6. InVitria Announces Launch of Recombinant Albumin for Diagnostics
7. InVitria Headlines Sponsorship of WilBio's Waterside Conference
8. InVitria Reveals Technology to Optimize Hybridoma Production Performance
9. InVitria to Present at BIO 2009 International Convention in Atlanta
10. InVitria Sponsors ESACT 2009 in Dublin, Ireland
11. InVitria Cell Culture Product Line to Headline PEACe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... Sam & Associates Insurance Agency, ... and related services to residents of the region, is embarking on a charity ... and wild lands. , Endangered Species International is committed to ending the anthropogenic ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... FL (PRWEB) , ... March 22, 2017 , ... An ... mosquitoes could occasionally transmit HIV, reports Leslie Norins, MD, PhD. He says ... cases of domestically transmitted Zika virus and in new infections with HIV. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Oklahoma City, OK (PRWEB) , ... March 22, ... ... firm offering insurance and financial planning services to regional families and business owners, ... provide meaningful support to young people in the area. , A growing number ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... FALLS, N.J. , March 22, 2017  CANTEL MEDICAL ... Jorgen B. Hansen , President and CEO, will be presenting ... Conference at the Westin Grand Central Hotel in ... Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, ... day. A live audio webcast will be ...
(Date:3/22/2017)... JACKSONVILLE, Fla. , March 22, 2017 /PRNewswire/ ... clinical-stage immuno-oncology company specializing in the development of ... of cancer and metastatic disease, today announced that ... Industry conferences. Dr. Glynn Wilson ... an overview of the company,s business, clinical pipeline ...
(Date:3/22/2017)... 22, 2017 Hologic, Inc. (Nasdaq: ... acquisition of Cynosure, Inc., a leader in medical aesthetics ... "We are pleased to complete our acquisition ... Michael Davin and the entire Cynosure team to ... medical aesthetics market," said Steve MacMillan , Hologic,s ...
Breaking Medicine Technology: